Global Celiac Drugs Market - Industry Trends and Forecast to 2028

Market Analysis and Insights: Global Celiac drugs Market

Celiac drugs market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 19.70% in the above-mentioned research forecast period. Increasing prevalence of celiac disease worldwide and increase in healthcare expenditure.

Moreover changing lifestyle and increasing awareness about healthcare also boost up the market growth. Moreover, vigorous research and development efforts and presence of novel pipeline drugs act as opportunity for the market growth. But, sometimes adverse effect related to drugs, strict regulatory framework and adoption of gluten free diet may hamper the global celiac drugs market.

Celiac disease is a chronic disease affects digestive system. This disease is caused due to immune reaction to gliadin, a protein founded in barley, wheat, rye and oats. Person affected experiences inflammation and destruction of the inner lining of small intestine. Symptoms reported include malabsorption of nutrients and minerals. Till now no particular cure has been discovered for treatment of celiac disease but still and extensive research is going on for providing effective drug that may have the capability to treat such a debilitating disease. However some corticosteroid, immunosuppressant drugs and biological therapies are indicated for several symptoms related to celiac disease.

This has been reported that one in every 141 Americans affected with celiac disease and it can target population of any age, hence expected to provide market with the lucrative growth. It is also estimated that celiac drugs market is growing with the CAGR of 19.70% in 2020.

This celiac drugs market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Celiac drugs Market Scope and Market Size

Celiac drugs market is segmented on the basis of type, application, route of administration, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of type, the celiac drugs market is segmented into biological drugs, immunosuppresants, corticosteroids. Corticosteroids segment is further segmented into prednisone, betamethasone, clobestasone butyrate. Immunosuppresants is further sub- segmented into azathioprine, infliximab, cyclosporine, cladribine among others. Others segment is further sub- segmented into dapsone, sulfonamide, topical corticosteroids or antihistamines.
• On the basis of application, the celiac drugs market is segmented into classical celiac disease, non- classical celiac disease, silent celiac disease.
• On the basis of route of administration, the celiac drugs market is segmented into topical, parenteral, oral, others.
• On the basis of end-users, the celiac drugs market is segmented into hospitals, specialty clinics, home healthcare, others.
• On the basis of distribution channel, the celiac drugs market has also been segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy, others.

Celiac drugs Market Country Level Analysis

Celiac drugs market is analysed and market size information is provided by country, type, application, route of administration, end-users and distribution channel as referenced above.

The countries covered in the celiac drugs market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

North America accounts the largest market share due to the growing incidence of celiac disease and lack of appropriate treatment options. Europe accounts the second largest market share due to wide distribution network of drugs and enhancing demand of effective treatment. Asia-Pacific is expected to account for the largest market share over coming years for the celiac drugs due to increase in pool of patients, increasing awareness about the disease, rising government funding for research activities.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Celiac drugs market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Celiac drugs Market Share Analysis

Celiac drugs market competitive landscape provides details by competitor details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to celiac drugs market.

The major players covered in the celiac drugs market are Avik Pharmaceutical Ltd., ImmunogenX, LLC., ImmusanT, Institute for Protein Design, Anokion, Protagonist Therapeutics, Inc., Takeda Pharmaceutical Company Limited, Amgen Inc., COUR Pharmaceuticals Development Company, Inc., Bausch Health Companies Inc., 9 Meters Biopharma Inc., Calypso Biotech, Zydus Pharmaceuticals, Inc., Nephron Pharmaceuticals Corporation, Samex Overseas, Vamsi Lab Ltd., Amneal Pharmaceuticals LLC, among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-59264